Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ecuadorian cacao beans contain high concentrations of flavonoids (catechin, epicatechin, procyanidins) that combat oxidative stress through free radical scavenging and NF-κB pathway inhibition. The methylxanthine theobromine (5.45-7.96 mg/g) provides vasodilatory effects and mild cardiac stimulation while supporting cardiovascular function.
Reported Benefits (Provisional)
Origin & History
The Ecuadorian Cacao Bean (Theobroma cacao) is native to the Amazon rainforest regions of Ecuador. It thrives in warm, humid climates with well-drained, fertile soils, producing high-quality, aromatic beans prized globally for their rich flavor and functional properties.
Research Narrative (Provisional)
Extensive research, including numerous clinical trials and meta-analyses, supports the cardiovascular, cognitive, and antioxidant benefits of cacao. Studies highlight its role in improving endothelial function, modulating blood pressure, and enhancing mood through its rich flavonoid and alkaloid content.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Flavonoids, polyphenols, theobromine, phenylethylamine. - Minerals: Magnesium, Iron, Copper. - Dietary Fiber: Supports digestive health. - Healthy Fats: Oleic acid.
Reported Mechanism (Provisional)
Flavonoids in Ecuadorian cacao modulate apoptosis through cytochrome c release, caspase-9/3 activation, Bcl-2 downregulation, and Bax/Bak upregulation while inhibiting NF-κB signaling pathways. These compounds suppress nitric oxide production in macrophages and regulate cytokine expression for anti-inflammatory effects. Theobromine acts as a vasodilator and muscle relaxant with mild cardiac stimulation, while caffeine enhances psychomotor activity.
Clinical Narrative (Provisional)
Current evidence is primarily limited to in vitro studies rather than human clinical trials. Laboratory research demonstrates cocoa extracts inhibit MCF-7 breast cancer cells with IC50 values of 41.43-329.67 μg/mL, with leaf extracts showing highest potency. Procyanidins induced mitochondrial depolarization and cell cycle arrest in cancer cell lines, though translation to human outcomes remains unestablished. Robust clinical trial data with specific endpoints and statistical significance is lacking for Ecuadorian cacao specifically.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.